Literature DB >> 17098326

Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases.

Masanori Nakanishi1, Yukihiro Umeda, Yoshiki Demura, Shingo Ameshima, Yukio Chiba, Isamu Miyamori, Takeshi Ishizaki.   

Abstract

Arterial infusion chemotherapy is considered to be a treatment option for lung cancer patients who are intolerant of systemic chemotherapy because of an increased risk of severe toxicity. However, a number of major studies regarding arterial infusion chemotherapy for lung cancer have reported disappointing results. We performed arterial infusion chemotherapy for four patients with advanced NSCLC who were unable to receive systemic chemotherapy or radiotherapy. After detecting the feeding arteries precisely by angiography, low-dose chemotherapeutic agents were administrated into the corresponding arteries. In each case, multiple feeding arteries including main feeding arteries other than the bronchial artery were detected and a partial response (PR) was obtained without severe toxicity in all. We consider that the present method is an effective treatment option for lung cancer patients who are restricted from undergoing standard systemic chemotherapy or radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098326     DOI: 10.1016/j.lungcan.2006.10.008

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival.

Authors:  Yu-Fei Fu; Yu Li; Ning Wei; Hao Xu
Journal:  Radiol Med       Date:  2016-03-31       Impact factor: 3.469

Review 2.  Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors.

Authors:  Thomas J Vogl; Mohammad Shafinaderi; Stefan Zangos; Sebastian Lindemayr; Khashayar Vatankhah
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

3.  Assessment of the feeding arteries by three-dimensional computed tomography angiography prior to multi-arterial infusion chemotherapy for lung cancer.

Authors:  Xiao-Dan Ye; Zheng Yuan; Jian-Ding Ye; Xiang-Sheng Xiao
Journal:  Oncol Lett       Date:  2012-10-26       Impact factor: 2.967

4.  Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer.

Authors:  Huiwei Qi; Sen Jiang; Dong Yu; Huijuan Ni; Qiong Hu; Jie Zhang
Journal:  Med Oncol       Date:  2015-10-23       Impact factor: 3.064

5.  Establishment of a large animal model for research on transbronchial arterial intervention for lung cancer.

Authors:  Zhichao Sun; Xiao An; Hongchao Liu; Weihua Dong; Xiangsheng Xiao
Journal:  Diagn Interv Radiol       Date:  2021-07       Impact factor: 2.630

6.  Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis.

Authors:  Yongjie Zhou; Xin Zhou; Jingqin Ma; Wen Zhang; Zhiping Yan; Jianjun Luo
Journal:  Cancer Manag Res       Date:  2021-03-01       Impact factor: 3.989

7.  Neoadjuvant chemotherapy by bronchial arterial infusion in patients with unresectable stage III squamous cell lung cancer.

Authors:  Jun Zhu; Hai-Ping Zhang; Sen Jiang; Jian Ni
Journal:  Ther Adv Respir Dis       Date:  2017-07-04       Impact factor: 4.031

8.  Achievable complete remission of advanced non-small-cell lung cancer: Case report and review of the literature.

Authors:  Ning-Ning Yang; Fei Xiong; Qing He; Yong-Song Guan
Journal:  World J Clin Cases       Date:  2018-07-16       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.